CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Associate Professor of Endocrinology and Metabolism, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo (FMUSP). Head of the Laboratory of Cellular and Molecular Endocrinology (LIM25).Metrics: Over 3,500 citations, 110 published articles, H-index = 32, 20 completed supervised theses (including 9 direct PhDs), 2 postdoctoral supervisions, and 6 direct PhDs in progress.Currently, Principal Investigator for two thematic FAPESP projects:1) Clinical and genetic aspects of endocrine hypertension.2) Collaborative project with the Institute of Technology at the University of Zurich (ETH) on Interstitial Monitoring of Steroids.International Groups and Society Activities:Chair of the Study Group on Pheochromocytomas and Paragangliomas of The American Australian Asian Adrenal Alliance (A5).President of the Adrenal and Hypertension Department of the Brazilian Society of Endocrinology and Metabolism (SBEM) (20212024).Member of the International Commission of SBEM (20252027).Editorial Activities:Deputy Editor of Archives of Endocrinology and Metabolism.Associate Editor of the Journal of The Endocrine Society.Member of the Editorial Board of the Journal of Clinical Endocrinology and Metabolism.Medical Positions:Attending Physician at the Adrenal Unit, Division of Endocrinology and Metabolism, Hospital das Clínicas, FMUSP.Physician at the São Paulo State Cancer Institute (ICESP), Hospital das Clínicas, FMUSP.Education and Training:Medical Residency in Internal Medicine and Endocrinology and Metabolism at Hospital das Clínicas, Faculty of Medicine, University of São Paulo (20012005).PhD in Endocrinology and Metabolism from FMUSP (20062008).Postdoctoral Fellowship at the National Institutes of Health (NIH, USA) in the Section on Endocrinology and Genetics (20082010).Research Focus: Primarily works in the field of Endocrinology and Metabolism, with emphasis on: Endocrine hypertension (primary aldosteronism, pheochromocytoma/paraganglioma). Endocrine oncology (pheochromocytoma, paraganglioma, adrenal cortex tumors, and thyroid cancer). Cushing syndrome. Molecular genetics of adrenal diseases.Awards: 2011 Early Investigator Award, The Endocrine Society; 2013 Young Investigator Award, Brazilian Society of Endocrinology and Metabolism (SBEM). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The adrenal steroids cortisol and aldosterone are critical components of the endocrine system. Their lack causes a life-threatening adrenal crisis, while overproduction leads to cardiovascular complications (e.g. hypertension and heart failure), metabolic disturbances, and psychological symptoms. These complications are potentially preventable if adrenal diseases are diagnosed and treated…
Arterial hypertension (AH) is an important cardiovascular risk factor, with an estimated prevalence of 10 to 40% of adults in developed countries. AH is primary or essential in the majority of the cases, but the prevalence of secondary AH increases to around 30% in young adults. Among patients with resistant AH, screening for primary aldosteronism (PA) and for catecholamine-secreting tumo…
Arterial hypertension (AH) is a major cardiovascular risk factor that affects 10% to 40% of the adult population in industrialized countries. Primary aldosteronism (PA) is the most common form of secondary hypertension with an estimated prevalence of approximately 10% in referred patients. In the last 5 years, considerable advances toward understanding of molecular genetics of aldosterone…
Adrenocortical cancer accounts for 0.05-0.2% of all cancers, with an estimated incidence of 0.5-2.0/million/year in adults. Interestingly, the incidence of pediatric adrenocortical tumors is remarkably high in South and Southern Brazil, where it is estimated to be 10-15 times greater than the worldwide incidence. There are currently few therapeutic options for patients with adrenocortical…
(Only some records are available in English at this moment)
The adrenal steroids cortisol and aldosterone are critical components of the endocrine system. Their lack causes a life threatening adrenal crisis, while overproduction leads to cardiovascular complications (e.g. hypertension and heart failure), metabolic disturbances, and psychological symptoms. These complications are potentially preventable if adrenal diseases are diagnosed and treated…
Primary aldosteronism (PA) is a condition characterized by the autonomous excessive secretion of aldosterone by the adrenal gland, not regulated by the renin-angiotensin-aldosterone system. PA is the most common cause of secondary hypertension and is associated with an increased cardiovascular risk. PA can be unilateral in 30-40% of cases or bilateral in 50-60% of cases. Familial PA is ra…
(Only some records are available in English at this moment)
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors arising from chromaffin cells of the adrenal medulla or extra-adrenal paraganglia, respectively. PPGLs have the highest degree of heritability among endocrine tumors. Currently, ~40% of individuals with PPGLs have a genetic germline and there are at least 12 different genetic syndromes related to these tumors, suc…
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors arising from chromaffin cells of the adrenal medulla (pheochromocytomas, 80%-85%) or extra-adrenal paraganglia (paragangliomas, 15%-20%), respectively. PPGLs have the highest heritability among endocrine tumors. Currently, about 40% of PPGL individuals have a genetic germline mutation and at least 12 different gen…
(Only some records are available in English at this moment)
Primary aldosteronism (PA) is the most common form of secondary hypertension, with a prevalence of approximately 20% in patients with resistant hypertension. In the last decade, considerable advances have been made towards the better understanding of PA genetics. Somatic pathogenic variations in KCNJ5, CACNA1D, ATP1A1 and ATP2B3 genes, which are involved in maintaining intracellular ionic…
| 2 / 2 | Ongoing grants |
| 5 / 4 | Completed research grants |
| 8 / 8 | Ongoing scholarships in Brazil |
| 11 / 11 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 27 / 26 | All research grants and scholarships |
| Associated processes | |